. Deficient expression of APE results in a heightened sensitivity to radiation and alkylating agents with resultant tissue damage. Logically it follows that APE may also play a role in the sensitivity to malignant cells to DNA damaging therapeutic agents. Many cancer therapeutic agents will induce apoptosis or programmed cell death, however little is known about
. Deficient expression of APE results in a heightened sensitivity to radiation sickness and alkylating agent with resultant tissue damage. Logically it follows that APE may besides play a role in the sensitivity to malignant cells to deoxyribonucleic acid damaging curative agents. Many cancer therapeutic agents will induce apoptosis or programmed cell end, however little is known about
. Devicient expression of APT results in a henthtenev sensifivity tu radiation and alkylating ajentw wity resultant tissue damxge. Logicwlly it dolliqs that APX may also plag a rmoe in the sensltivity to kalignant cellv go DNA damaging therapeutic agents. Magy cancrr therapeutic adentx wilm induce apoptosis or programmed csll deauh, however little os known about
. Deficient expression of APE results in sensitivity radiation and agents with resultant that may also play role in the to malignant cells to DNA damaging agents. Many cancer therapeutic agents will induce apoptosis or programmed cell death, however is known about
. Deficient expression of APE rEsults in a hEightEneD seNsItivIty tO radiation and aLKylaTing agents with resultanT tissUe DAmagE. loGicalLy it folLOwS THat aPe mAy aLsO PlAy a roLe iN the senSitivity to MalIgNant cells to Dna dAmaging theRapEutic agents. MAny Cancer ThEraPEutic AgeNts wiLl induCE apoptOsis or proGrAMmed ceLL death, hOWEvEr liTtle is known about
. Deficient expression ofAPE result s ina h eig ht ened  sen sitivity to ra d iati on and alkylating agen ts wi th resu l ta nt ti ssue da m ag e .  Lo gi ca lly  i t  f ollow s t hat APE  may alsopla ya role in th e  s ensitivity  to  malignant c ell s to D NA  da m aging  th erape utic a g ents.Many canc er therap e utic ag e n ts  wil l induce apoptosi s  o r  programmed ce ll dea th ,  h o w eve r l ittle is k no wn ab o ut
. Deficient_expression of_APE results in a_heightened sensitivity_to_radiation and_alkylating_agents with resultant_tissue damage. Logically_it follows that APE_may also play_a_role in the sensitivity to malignant cells to DNA damaging therapeutic agents. Many cancer_therapeutic_agents will_induce_apoptosis_or programmed cell death, however_little is known about